Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation SDVOSBC Expired 4 notices 1 document

6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement 36C24826Q0145

Solicitation 36C24826Q0145 Copied Notice ID 3608f51d7a634569be3479f2e0b5950f Copied VETERANS AFFAIRS, DEPARTMENT OF — 248-NETWORK CONTRACT OFFICE 8 (36C248)
SAM.gov
Posted
Dec 10, 2025
Deadline
Dec 29, 2025
Set-aside
SDVOSBC
NAICS
621511
PSC
6640

Summary

AI-generated · Dec 11, 2025

Procure a Thyroid Cancer Molecular Test to support diagnostic services at the Orlando VA Healthcare System and the Caribbean VA Healthcare System. The contract will be firm-fixed-price and run from award through completion; bidders should monitor sam.gov for amendments, as no hard copies will be mailed, and eligibility requires registration in the System for Award Management (SAM).

The Orlando VA Healthcare System and Caribbean VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test. The performance period for this contract will be date of award to date of completion. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511, with a related small business size standard of $41.5 Million. The proposed action is for Firm-Fixed Price (FFP) requirement contract, which will be advertised as a set aside to service-disabled veteran owned small business on or about 15 December 2025, via sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. For further information, please contact Yolanda Glover, Contract Specialist at Yolanda.Glover@va.gov.

From Presolicitation posted on Dec 10, 2025

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation document will not be issued. This solicitation is a Request for Quote (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 effective 10/01/2025. The Caribbean VA Healthcare System and Orlando VA Healthcare System is seeking to procure Thyroid Cancer Molecular Test, as defined in the Statement of Work (SOW). This will be a Base and Four (4) 12-month options. This requirement is solicited as a Service-Disabled Veteran Owned Small Business (SVOSB) set-aside. All offerors must be verified in the U.S. Small Business Administration Page, https://veterans.certify.sba.gov/, and must be registered in System for Award Management (SAM) at https://www.sam.gov to be considered for an award of a federal contract registered in the record must be complete and not missing elements such as representations and certifications. Amendments to the RFQ will be posted to this website only. All Offerors must obtain amendments at this website; hard copies will not be mailed. The contractor must ensure that we receive the proposal on time; NO late proposals will be accepted/ considered. The associated North American Industrial Classification System (NAICS) code for this procurement is 621511 with a small business size standard of $41.5M. The FSC/PSC is 6640. See Section B.2 Price/Cost Schedule for a list of Line Items and enter your pricing accordingly. See Section B.4 Statement of Work for a description of the services to be performed. The Government will evaluate all quotations using the Comparative Evaluation process outlined in FAR 13.106-2, A comparative evaluation process is appropriate when it may be in the best interest of the Government to consider award to other than the lowest priced offeror or other than the highest technically rated offeror. See E.1 52.212-1 Instructions to Quoters and E.2 52.212-2 Evaluation of Quotes for more information. Any questions or concerns regarding this solicitation should be submitted no later than 01/12/2026 at 12:00 PM EST. No further questions will be accepted after that date and time. Please submit questions in writing via e-mail to the Contracting Officer, Yolanda Glover, at yolanda.glover@va.gov. All quotations for this solicitation shall be submitted no later than 01/20/2026 at 4:00 PM EST. Please submit all responses to the Contracting Officer, Yolanda Glover, at yolanda.glover@va.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c). *Note* To prepare / complete a Quote, See Offerors Checklist under 52.212-2 Evaluation Commercial Items.

From Combined Synopsis/Solicitation posted on Jan 07, 2026

This is Amendment A0001 to Solicitation 36C24826Q0145 Thyroid Cancer Molecular Test to answer vendor questions, provide Revised SF1449, Revised Oppotunities Description, B.2 Revised Price/Cost Schedule, B.4 Revised Statement of Work, and D.1 Vendor Questions and Answers. All Offerors must acknowledge this amendment and submit their proposals on B.2 Revised Price/Cost Schedule included in this amendment. Please submit all Proposals to the Contracting Officer, Yolanda Glover, at yolanda.glover@va.gov by Thursday January 22nd 2026 no later than 4 pm EST. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c).

From Combined Synopsis/Solicitation posted on Jan 12, 2026

The purpose of this amendment to Solicitation 36C24826Q0145 for Thyroid Cancer Molecular Test for Orlando VA Health Care System and Caribbean Health Care System is to close RFQ 36C24826Q0145. No award could be made at this time. Another solicitation will be issued at a later date.

From Combined Synopsis/Solicitation posted on Feb 05, 2026

Notice history

4
  1. Presolicitation Posted Dec 10, 2025
  2. Combined Synopsis/Solicitation Posted Jan 07, 2026
    • Title: 6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement
    • Description: Description was updated
    • Notice Type: PresolicitationCombined Synopsis/Solicitation
    • Response Deadline: Dec 29, 2025Jan 20, 2026
  3. Combined Synopsis/Solicitation Posted Jan 12, 2026
    • Description: Description was updated
    • Response Deadline: Jan 20, 2026Jan 22, 2026
    • Set-Aside: Service-Disabled Veteran-Owned Small Business Set AsideNone
  4. Combined Synopsis/Solicitation LATEST Posted Feb 05, 2026
    • Description: Description was updated
    • Response Deadline: Jan 22, 2026Mar 06, 2026

Details

Solicitation number 36C24826Q0145
Notice ID 3608f51d7a634569be3479f2e0b5950f
Notice type Presolicitation
Product / Service (PSC) 6640
NAICS 621511
Place of performance USA
Archive date Jan 28, 2026

Award Information

Awardees
0

Documents

1
View on SAM.gov

Contacts

primary
Yolanda Glover

Contracting Officer

Email

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
248-NETWORK CONTRACT OFFICE 8 (36C248)

Place of Performance

Orlando VA Healthcare System
Caribbean VA Healthcare System

USA

Dates

Posted Dec 10, 2025 7 months ago
Last Updated Aug 06, 2026 2 days ago
Due Dec 29, 2025 7 months ago